Literature DB >> 15194243

Cavitary pneumonia secondary to Tsukamurella in an AIDS patient. First case and a review of the literature.

Maria Luisa Alcaide1, Luis Espinoza, Lilian Abbo.   

Abstract

Tsukamurella is a Gram-positive, variable rod-shaped, weakly acid-alcohol-fast, non motile, aerobic bacterium that belongs to the genus Rhodococcus. Tsukamurella has been reported as a cause of infections in humans with immunosuppression and indwelling foreign bodies. It has also been isolated in one patient with AIDS (Acquired Immunodeficiency Syndrome) as a saprophytic organism. Optimal management of infections secondary to this micro-organism is still uncertain due to the paucity of cases. The combination of a beta-lactam and an aminoglycoside, along with removal of medical devices, appear to be the treatment of choice. We report the case of an AIDS patient who presented with multiple lung cavitary lesions secondary to Tsukamurella. This is the first case reported of Tsukamurella as a pathogenic agent in an AIDS patient. We also propose a successful oral antibiotic regimen with fluoroquinolone and rifampin to treat infections secondary to this uncommon micro-organism.

Entities:  

Mesh:

Year:  2004        PMID: 15194243     DOI: 10.1016/S0163-4453(03)00139-7

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Brain abscess caused by Tsukamurella tyrosinosolvens in an immunocompetent patient.

Authors:  Wang-Huei Sheng; Yu-Tsung Huang; Shan-Chwen Chang; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

2.  Tsukamurella: a cause of catheter-related bloodstream infections.

Authors:  E Bouza; A Pérez-Parra; M Rosal; P Martín-Rabadán; M Rodríguez-Créixems; M Marín
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-23       Impact factor: 3.267

3.  Tsukamurella tyrosinosolvens--an unusual case report of bacteremic pneumonia after lung transplantation.

Authors:  Armelle Ménard; Sébastien Degrange; Olivia Peuchant; Thi Diem Tien Nguyen; Claire Dromer; Jeanne Maugein
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-11-12       Impact factor: 3.944

4.  Tsukamurella tyrosinosolvens bacteremia with coinfection of Mycobacterium bovis pneumonia: case report and literature review.

Authors:  Chang-Hung Chen; Chao-Tai Lee; Tsung-Chain Chang
Journal:  Springerplus       Date:  2016-11-29

5.  MALDI-TOF MS for identification of Tsukamurella species: Tsukamurella tyrosinosolvens as the predominant species associated with ocular infections.

Authors:  Jade L L Teng; Ying Tang; Samson S Y Wong; Jordan Y H Fong; Zhe Zhao; Chun-Pong Wong; Jonathan H K Chen; Antonio H Y Ngan; Alan K L Wu; Kitty S C Fung; Tak-Lun Que; Susanna K P Lau; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2018-05-09       Impact factor: 7.163

6.  Structural elucidation of Tsukamurella pulmonis neutral polysaccharide and its visualization in infected mouse tissues by specific monoclonal antibodies.

Authors:  Adnan Saeed; Mariola Paściak; Sabina Górska; Ireneusz Ceremuga; Elżbieta Gamian; Piotr Ziółkowski; Marek Drab; Andrzej Gamian
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

7.  Tsukamurella pulmonis conjunctivitis in patients with an underlying nasolacrimal duct obstruction - report of two cases.

Authors:  Peter Kechker; Yigal Senderovich; Shifra Ken-Dror; Sivan Laviad-Shitrit; Malka Halpern
Journal:  Access Microbiol       Date:  2020-12-09

8.  Coexistence of primary adenocarcinoma of the lung and Tsukamurella infection: a case report and review of the literature.

Authors:  Vinicio A de Jesus Perez; Jeffrey Swigris; Stephen J Ruoss
Journal:  J Med Case Rep       Date:  2008-06-14

Review 9.  Role of Tsukamurella species in human infections: first literature review.

Authors:  S Safaei; M Fatahi-Bafghi; Omid Pouresmaeil
Journal:  New Microbes New Infect       Date:  2017-10-10

Review 10.  Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review.

Authors:  Jun Suzuki; Teppei Sasahara; Masaki Toshima; Yuji Morisawa
Journal:  BMC Infect Dis       Date:  2017-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.